The present review provides an overview of recent findings on new members of the protein disulfide isomerase (PDI) family required for thrombosis.
INTRODUCTION
Protein disulfide isomerase (PDI) was known for several decades as an endoplasmic reticulum protein that formed disulfide bond in nascent proteins. The demonstration of a secreted platelet PDI [1] helped open a new field of research on extracellular PDIs. PDI was the first member of this family shown to have a role in platelet integrin-mediated platelet aggregation and adhesion [2, 3] , and to support thrombosis in vivo [4, 5] . Subsequently, ERp57 [6] [7] [8] [9] Recent efforts have used specific antibodies, targeted knockout mice, and in-vivo imaging of thrombosis along with in-vitro studies to characterize these PDIs. The feasibility of inhibiting PDI to prevent thrombosis in humans has been studied [13 & ]. Substrates of PDI include adhesive proteins and integrins. However, much is yet unknown about the relevant substrates, the reactions catalyzed, and how these enzymes work together in a coordinated fashion to support platelet function and thrombosis.
PROTEIN DISULFIDE ISOMERASE, ERp57, ERp5, AND ERp72 ARE REQUIRED FOR PLATELET FUNCTION AND COAGULATION
There are now over 20 members of the PDI family of enzymes; seven of these contain the CGHCactive site motif [14, 15] . Four CGHC-active site containing members of the PDI family have important roles in platelet function and thrombosis [4] [5] [6] [7] [8] [9] [10] 11 && ,12 && , [16] [17] [18] (Fig. 1) . The prototypic PDI contains four domains arranged in order of a-b-b 0 -a 0 , with a 19 amino acid linker between the b 0 and a 0 domains termed x ( Fig. 1 ) [19] . The b and b 0 domains are noncatalytic, with the hydophobic b 0 domain providing the principle substrate-binding domain of PDI. The a and a 0 domains of each PDI illustrated contain redox active CGHC motifs with ERp72 having a third a8 CGHC motif at the N-terminal region. The cysteine (Cys) in these motifs are in equilibrium between dithiol and disulfide forms; the dithiol form catalyzes cleavage and isomerization of disulfide bonds, whereas the disulfide form of the motif oxidizes thiols to disulfides [20] . [19, 21] . Instead hydrophobic patches in the a8, a, and a 0 active site domains of ERp72 mediate substrate binding [22] . Although the two noncatalytic b and b 0 domains of ERp72 are similar to ERp57, surface charge differences allow the b 0 domain of ERp57, but not ERp72, to bind calnexin [22] . ERp5 lacks a typical b 0 domain. Differences in enzyme substrate binding ability contribute to differences in selectivity for substrates, or selectivity for specific Cys residues in a given substrate [23, 24] . && ] also found a role for ERp72 in platelet function and thrombosis. The anti-ERp72 antibody inhibited platelet aggregation, aIIbb3 activation, P-selectin expression, calcium mobilization, and platelet adhesion to fibrinogen. ERp72 supported clot retraction, suggesting that ERp72 affinity regulation of fibrinogen binding results in outside-in signaling through aIIbb3. Infusion of anti-ERp72 into mice had a protective effect against thrombosis. Thus, two recent studies highlight an important role for intravascular ERp72 in the regulation of platelet function and thrombosis.
SUBSTRATES OF VASCULAR DISULFIDE ISOMERASES
Substrates of the disulfide isomerases include adhesive proteins, integrins, and potentially coagulation factors. The first known extracellular substrate of platelet PDI was the adhesive protein thrombospondin 1 [25] . PDI directly catalyzed thiol-disulfide exchange in thrombospondin 1, resulting in a conformational change affecting its cell adhesive properties.
INTERACTIONS OF PROTEIN DISULFIDE ISOMERASE, ERp57, ERp5, and ERp72 WITH THE aIIbb3 FIBRINOGEN RECEPTOR PDI mediates platelet aggregation [2] , a process requiring activation of the aIIbb3 integrin. Several
KEY POINTS
ERp72 is the latest member of the PDI family found to be required for platelet function and thrombosis.
PDI, ERp57, ERp5 and ERp72 are required for platelet accumulation and fibrin deposition in vivo.
PDI, ERp57, ERp5, and ERp72 function by different mechanisms in platelet aggregation.
The C-terminal or a 0 active sites in PDI and ERp57, and the a and a 0 active sites in ERp72, are required for platelet aggregation and secretion, and thrombosis.
Integrins and adhesive proteins represent substrates of disulfide isomerases. lines of evidence support a direct interaction of PDI with the aIIbb3 integrin. First, PDI binds to Mn 2þ -treated CHO cells expressing aIIbb3, but not to cells expressing P-selectin [26] . Second, PDI reacts with Mn 2þ -treated aIIbb3, or the b3 subunit, by surface plasmon resonance (Kd1 mM) [26] . Third, PDI binds to thrombin-activated or Mn 2þ -treated wildtype mouse platelets but not to platelets lacking aIIbb3 [16, 17] . ERp5 immunoprecipitated with the b3 subunit of aIIbb3 from activated platelets; the b3 subunit also co-precipitated with ERp5 [18] . ERp5 also binds to intact aIIbb3 or the b3 subunit by surface plasmon resonance (Kd21 mM) [ 
ERp72 GENERATES THIOLS IN aIIbb3
Adding ERp72 to human platelets potentiated thiollabeling of sulfhydryl's in aIIb and b3 (Fig. 2) , and platelet aggregation [11 && ]. This suggests ERp72 cleaves disulfide bonds in aIIb and b3 facilitating activation of aIIbb3. Binding of substrates to ERp72 (or PDI) displaces the x-linker enhancing reductase activity [27 & ]. This could potentiate the generation of thiols in aIIb and b3 by ERp72.
REACTIONS INVOLVING THIOLS AND DISULFIDES IN aIIbb3
Reactions involving thiols and disulfides in aIIbb3 were characterized by labeling aIIbb3 purified from nonactivated and activated platelets with the sulfhydryl-reactive biotin-HPDP (Fig. 3) [11 && ]. Using LC-MS/MS, a total of 12 and 14 different labeled cysteine residues were reproducibly identified in nonactivated and activated aIIbb3, respectively [11 && ]. Because there are only 2.6 thiol/mol of inactivated aIIbb3 and 4.4 thiol/mol of activated aIIbb3 [28] , these findings imply that each of the labeled Cys is a free thiol in only a fraction of aIIbb3 molecules, and that the position of the thiol varies through thiol-disulfide exchange. This is consistent with reports showing a role for thiol-disulfide exchange in the activation of aIIbb3 [28, 29] .
Some of the thiol-containing Cys that were identified in the b3 subunit are functional (allosteric) disulfide bonds [30] predicted by structural studies to be easily broken (Cys184, Cys635, and Cys687) [31, 32] . Cys residues in aIIb were also labeled, with Cys484 and Cys490 only labeled in the activated aIIb subunit [11 && ]. Previous work showed that redox-sensitive disulfide bonds in aIIbb3 were cleaved by low concentrations of reduced glutathione generating thiols in aIIbb3 and potentiating platelet aggregation [33] ; and that vicinal thiols (di-thiols that interconvert with disulfide bonds) have a role in activation of aIIbb3 [34] . Together these studies indicate a role for reactive thiols and disulfide bonds that may be the targets of ERp72 or other platelet PDIs.
Although not all the thiol-containing Cys that were identified [11 && ] are predicted to be from functional disulfide bonds in the crystal structure [32, 35] , the protein backbone and disulfide bonds that link it can change shape when in solution or when the protein is in a membrane [31] . Cleavage of the bond may only occur when the disulfide bonds adopts a particular configuration, which could be controlled by inside-out conformation changes induced by platelet activation, ligand binding [36] , or mechanical shear in the circulation.
POTENTIAL MECHANISMS OF ACTIVATION OF aIIbb3 By DISULFIDE ISOMERASES
It is possible that aIIbb3 is a direct target of several disulfide isomerases. In the endoplasmic reticulum some proteins are substrates of multiple members of Protein disulfide isomerases in thrombosis Essex and Wu the PDI family [23] . Laminin and thyroglobulin are large heavily disulfide-linked proteins that form mixed disulfides with four members of the PDI family, with each PDI targeting different Cys to contribute to oxidative folding [23, 24] . Similarly, multiple members of the PDI family act distinctly and coordinately on the polyomavirus [37] , simian virus, [38] , and bovine pancreatic trypsin inhibitor [39] . aIIbb3 is a large disulfide-linked complex and the complimentary enzymatic activities of multiple members of PDI family are required for optimal activation of the receptor. While the stoichiometry of interactions of PDI, ERp57, ERp5, and ERp72 with aIIbb3 is unknown, a single PDI molecule could interact with multiple molecules of aIIbb3. Alternatively, a subpopulation of aIIbb3 that controls platelet aggregation could be targeted. For example, a subpopulation of aIIbb3 that interacts with the platelet cytoskeleton is required for activation of aIIbb3 [40] , and activation of individual aIIbb3 molecules rapidly initiates aIIbb3 clustering of intracellular signal-generating complexes [41] . Thus, a limited number of disulfide isomerase-catalyzed reactions targeting a subpopulation of aIIbb3 molecules could amplify platelet responses required for aggregation.
The PDIs could catalyze sequential or simultaneous reactions in aIIbb3. Release of clientsubstrates from PDI after the reaction cycle is completed [42] , would allow access for another member of the PDI family to catalyze a subsequent reaction [37] . It is also possible could act in series, rather than in parallel, with one member of the PDI family affecting the activity of second PDI. Such a redox communication network among PDIs facilitates efficient disulfide bond formation in the mammalian endoplasmic reticulum [43] . Thus, the PDIs could act in sequential fashion in one of two ways: one PDI may generate thiols in aIIbb3 whereas another PDI subsequently catalyzes a thiol-disulfide exchange reaction; or one PDI acting on another PDI that in turn acts on aIIbb3.
WORKING MODEL OF THE ROLE OF DISULFIDE ISOMERASES AND THIOLS IN ACTIVATION OF THE aIIbb3 INTEGRIN

Working model
The working model (Fig. 4) focuses on interrelations of the PDIs and the integrin aIIbb3 in platelet aggregation. The major points are: agonist stimulation causes platelet activation resulting in talin binding to the b3 cytoplasmic domain of aIIbb3 [36] . This initiates inside-out signaling resulting in low-affinity binding of fibrinogen to aIIbb3 (1); this is followed by further conformational changes in aIIbb3 that are facilitated by disulfide isomerase catalyzed events (2). These isomerase-catalyzed events include thiol-disulfide exchange, although reduction of disulfide bonds or oxidation of thiols are also possible. Thiol-disulfide rearrangement in aIIbb3 facilitates formation of the high affinity/avidity state. The interaction of PDIs with aIIbb3 may be direct [44] , at least for a population of aIIbb3. External GSH (or low molecular weight thiol/disulfide pairs) or a transplasma membrane NAD(P)H-dependent reductase generate sulfhydryls in PDI or aIIbb3 potentiating the reactions [33, 45, 46] . There are likely multiple substrates of the PDIs on the platelet surface. The secreted platelet proteins thrombospondin 1 and vitronectin are PDI substrates with roles in platelet function [25,47, ]. These included vitronectin, complement factor 3, complement factor 5, C4b-binding protein, a2-macroglobulin, protein S, and CD5 antigen-like protein. These findings raise important possibilities requiring further study on the roles of these proteins in platelet function and thrombosis.
VITRONECTIN AS A PROTEIN DISULFIDE ISOMERASE SUBSTRATE
Vitronectin has emerged as a potentially important PDI substrate. Using an antibody to vitronectin with fluorescent imaging, in-vivo deposition of vitronectin was decreased when anti-PDI antibodies were infused into mice [48 & ]. Mice deficient in vitronectin had decreased platelet accumulation and fibrin deposition. PDI cleaved disulfides (Cys137-Cys161 and Cys274-Cys453) in vitronectin, and reduction of vitronectin by PDI enabled binding to b3 integrins. ERp57 did not catalyze these reactions. (2) represented by secondary platelet aggregation. During platelet activation, sulfhydryls are generated in aIIbb3 and in the active site of PDI from cytoplasmic reducing equivalents supplied by NAD(P)H. GSH or other low molecular weight thiols in the external redox environment also generate sulfhydryls in both aIIbb3 and PDI facilitating the reactions shown.
THE ROLE OF PDI IN COAGULATION REACTIONS
PDI, ERp57, ERp5, and ERp72
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PDI modulates tissue factor [50] , and factor XI activation [51] . PDI also has a role in activation of platelet factor V, although it is not known if this is because of a direct effect of PDI on factor V, or to release of platelet factor V from multimerin, which binds factor V in the a-granules of platelets [13
SECRETION OF DISULFIDE ISOMERASES AT THE SITE OF VASCULAR INJURY
Platelets and endothelial cells are the principal sources of the extracellular disulfide Isomerases at the side of vessel injury [4,5,8-10,11 && ,16,54] . This is not unexpected, considering the immediate proximity of platelets and endothelial cells to the site of injury, and the ability of these cells to secrete disulfide isomerases [7, 8, 10, 16, 54, 55] . PDI, ERp5, ERp57, and ERp72 are present on the resting platelet surface, and the levels increase following platelet activation [7, 8, 18, 56] . PDI and ERp57 are found in the dense tubular system (DTS) of platelets and are released on the surface of activated platelets in an actin-dependent process [57, 58] . Although thrombin-activated platelets only secrete 10% of total platelet PDI [55] , this is sufficient to support platelet accumulation in vivo [4, 5, 16, 17] . PDI activity is detected at the core of the platelet thrombus that contains the most highly activated platelets [59] . Endothelial cells provide another source of these enzymes at the site of vascular injury, and physiological levels of arterial laminar shear have been shown to greatly enhance externalization of endothelial-cell PDI, predominantly by a golgi-independent route [60] .
DISULFIDE ISOMERASE INHIBITORS AS ANTITHROMBOTIC THERAPY
Administration of an oral PDI inhibitor, isoquercitin, inhibits platelet-dependent thrombin generation in healthy humans and patients with antiphospholipid antibodies by 50 [64] . It is unknown whether targeting one of these PDI-family members has benefits over targeting the traditional PDI, or whether targeting several PDIs simultaneously would provide optimal antithrombotic therapy. Dual inhibition of platelets and coagulation with both antiplatelet agents and anticoagulants may become the standard of care for cardiovascular diseases [65, 66] . Inhibiting the appropriate member(s) of PDI family is appealing, as this could provide dual inhibition with a single agent.
CONCLUSION
Substantial progress has been made recently in the discovery of new disulfide isomerases required for thrombosis. However, we are only beginning to understand how this extracellular network of enzymes controls thrombosis. Two important issues that need to be addressed are: what is the full complement of disuflde isomerases required for platelet function and thrombosis, and how do all these disulfide isomerases act together to achieve thrombosis. Rearrangement of disulfide bonds may be part of a cascade of events that couples platelet stimulation to the various responses including aggregation and secretion. Dissecting out the key target Cys/ disulfide bonds for each PDI and/or the reactions each one catalyzes will provide a novel concept of how major functional receptors are regulated by multiple PDIs. The knowledge gained should enable a more in-depth understanding of diseases in which platelets are involved, and lead to interventions that alleviate these diseases.
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